Modulation of PLA2G12B activity may have particular therapeutic value for the treatment of familial lipase deficiencies, such as lipoprotein lipase (LPL) mutants70,71. Here, PLA2G12B is linked to hyperinsulinemic hypoglycemia, familial, 4.